These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

993 related articles for article (PubMed ID: 15634759)

  • 41. Insulin restores differentiation of Ras-transformed C2C12 myoblasts by inducing NF-kappaB through an AKT/P70S6K/p38-MAPK pathway.
    Conejo R; de Alvaro C; Benito M; Cuadrado A; Lorenzo M
    Oncogene; 2002 May; 21(23):3739-53. PubMed ID: 12032842
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Maspin controls mammary tumor cell migration through inhibiting Rac1 and Cdc42, but not the RhoA GTPase.
    Shi HY; Stafford LJ; Liu Z; Liu M; Zhang M
    Cell Motil Cytoskeleton; 2007 May; 64(5):338-46. PubMed ID: 17301947
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rho family GTPases cooperate with p53 deletion to promote primary mouse embryonic fibroblast cell invasion.
    Guo F; Zheng Y
    Oncogene; 2004 Jul; 23(33):5577-85. PubMed ID: 15122327
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells.
    Ulkü AS; Schäfer R; Der CJ
    Mol Cancer Res; 2003 Dec; 1(14):1077-88. PubMed ID: 14707291
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vav2 is an activator of Cdc42, Rac1, and RhoA.
    Abe K; Rossman KL; Liu B; Ritola KD; Chiang D; Campbell SL; Burridge K; Der CJ
    J Biol Chem; 2000 Apr; 275(14):10141-9. PubMed ID: 10744696
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influencing cellular transformation by modulating the rates of GTP hydrolysis by Cdc42.
    Fidyk N; Wang JB; Cerione RA
    Biochemistry; 2006 Jun; 45(25):7750-62. PubMed ID: 16784226
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Single point mutations in the SH2 domain impair the transforming potential of vav and fail to activate proto-vav.
    Katzav S
    Oncogene; 1993 Jul; 8(7):1757-63. PubMed ID: 8510922
    [TBL] [Abstract][Full Text] [Related]  

  • 48. c-Src-p38 mitogen-activated protein kinase signaling is required for Akt activation in response to ionizing radiation.
    Kim MJ; Byun JY; Yun CH; Park IC; Lee KH; Lee SJ
    Mol Cancer Res; 2008 Dec; 6(12):1872-80. PubMed ID: 19074832
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor.
    Bustelo XR; Suen KL; Leftheris K; Meyers CA; Barbacid M
    Oncogene; 1994 Aug; 9(8):2405-13. PubMed ID: 8036025
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ras effector pathways modulate scatter factor-stimulated NF-kappaB signaling and protection against DNA damage.
    Fan S; Meng Q; Laterra JJ; Rosen EM
    Oncogene; 2007 Jul; 26(33):4774-96. PubMed ID: 17297451
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells.
    Chen TH; Kao YC; Chen BC; Chen CH; Chan P; Lee HM
    Eur J Pharmacol; 2006 Jul; 541(3):138-46. PubMed ID: 16765938
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rho family proteins and Ras transformation: the RHOad less traveled gets congested.
    Zohn IM; Campbell SL; Khosravi-Far R; Rossman KL; Der CJ
    Oncogene; 1998 Sep; 17(11 Reviews):1415-38. PubMed ID: 9779988
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vav-family proteins in T-cell signalling.
    Tybulewicz VL
    Curr Opin Immunol; 2005 Jun; 17(3):267-74. PubMed ID: 15886116
    [TBL] [Abstract][Full Text] [Related]  

  • 54. RhoA and Rac1 signals in fMLP-induced NF-kappaB activation in human blood monocytes.
    Chen LY; Ptasznik A; Pan ZK
    Biochem Biophys Res Commun; 2004 Jun; 319(2):629-35. PubMed ID: 15178452
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vav: function and regulation in hematopoietic cell signaling.
    Bonnefoy-Bérard N; Munshi A; Yron I; Wu S; Collins TL; Deckert M; Shalom-Barak T; Giampa L; Herbert E; Hernandez J; Meller N; Couture C; Altman A
    Stem Cells; 1996 May; 14(3):250-68. PubMed ID: 8724692
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product.
    Crespo P; Schuebel KE; Ostrom AA; Gutkind JS; Bustelo XR
    Nature; 1997 Jan; 385(6612):169-72. PubMed ID: 8990121
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phosphorylation of tyrosine 1214 on VEGFR2 is required for VEGF-induced activation of Cdc42 upstream of SAPK2/p38.
    Lamalice L; Houle F; Jourdan G; Huot J
    Oncogene; 2004 Jan; 23(2):434-45. PubMed ID: 14724572
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
    Du J; Jiang B; Coffey RJ; Barnard J
    Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Point mutations of 3BP2 identified in human-inherited disease cherubism result in the loss of function.
    Miah SM; Hatani T; Qu X; Yamamura H; Sada K
    Genes Cells; 2004 Nov; 9(11):993-1004. PubMed ID: 15507112
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vav: a potential link between tyrosine kinases and ras-like GTPases in hematopoietic cell signaling.
    Hu P; Margolis B; Schlessinger J
    Bioessays; 1993 Mar; 15(3):179-83. PubMed ID: 8489524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.